Oruka Therapeutics, Inc. ORKA Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Oruka Therapeutics, Inc. (ORKA) reported deferred tax assets and other non-current assets of $103K in Q1 2026.
- How has Oruka Therapeutics, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Oruka Therapeutics, Inc.'s deferred tax assets and other non-current assets decreased by 0.0% year-over-year, from $103K to $103K.
- What is the long-term trend for Oruka Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s deferred tax assets and other non-current assets has grown at a 53.7% compound annual growth rate (CAGR), from $12K to $103K.